Jon‐Magnus Tangen
- Hematology top 5%
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 3
- Multiple Myeloma Research and Treatments 2
- Genetics top 10%
- Pharmacology top 10%
- Fungal Biology and Applications 5
- Phytochemistry and Bioactivity Studies 2
- Emergency Medicine top 10%
- Pharmacology top 10%
- Fungal Biology and Applications 5
- Phytochemistry and Bioactivity Studies 2
-
- Childhood Cancer Survivors' Quality of Life 5
-
- Neutropenia and Cancer Infections 5
-
- Cancer-related cognitive impairment studies 2
- Co-authors
- Geir HetlandEva Hellström-LindbergMagnus CarlssonGunnar ÖbergIngemar WinqvistJan CarneskogIngunn DybedalGunnar Grimfors
- Cited by
- HematologyGeneticsPharmacology
- Partner nations
- NorwaySwedenUnited States
In The Last Decade
Jon‐Magnus Tangen
24 papers receiving 596 citations
Peers
Comparison fields: 5 of 75
- Hematology 350
- Genetics 146
- Pharmacology 123
- Emergency Medicine 63
- Pharmacology 55
Countries citing papers authored by Jon‐Magnus Tangen
This map shows the geographic impact of Jon‐Magnus Tangen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon‐Magnus Tangen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon‐Magnus Tangen more than expected).
Fields of papers citing papers by Jon‐Magnus Tangen
This network shows the impact of papers produced by Jon‐Magnus Tangen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon‐Magnus Tangen. The network helps show where Jon‐Magnus Tangen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jon‐Magnus Tangen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 85 | |
| 2 | 2018 | 2 | |
| 3 | 2017 | 8 | |
| 4 | 2015 | 43 | |
| 5 | 2014 | 7 | |
| 6 | 2012 | 19 | |
| 7 | 2011 | 3 | |
| 8 | 2010 | 2 | |
| 9 | 2010 | 4 | |
| 10 | Overlevelse hos voksne med akutt myelogen leukemi | 2008 | 1 |
| 11 | 2008 | 12 | |
| 12 | 2005 | 31 | |
| 13 | 2005 | 37 | |
| 14 | [Empirical antibiotic treatment of patients with acute myelogenous leukemia]. | 1999 | 2 |
| 15 | 1997 | 1 | |
| 16 | 1994 | 1 | |
| 17 | 1993 | 52 | |
| 18 | 1990 | 6 | |
| 19 | 1988 | 14 | |
| 20 | [Acute lymphatic leukemia. Acute psychosis during induction treatment]. | 1987 | 0 |
About Jon‐Magnus Tangen
Jon‐Magnus Tangen is a scholar working on Hematology, Genetics and Pharmacology, having authored 25 papers that have together received 621 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Neutropenia and Cancer Infections (5 papers), Fungal Biology and Applications (5 papers), Hematopoietic Stem Cell Transplantation (3 papers), Phytochemistry and Bioactivity Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Cancer-related cognitive impairment studies (2 papers). The work is most often cited by research in Hematology (350 citations), Genetics (146 citations) and Pharmacology (123 citations). Jon‐Magnus Tangen has collaborated with scholars based in Norway, Sweden and United States. Frequent co-authors include Geir Hetland, Eva Hellström-Lindberg, Magnus Carlsson, Gunnar Öberg, Ingemar Winqvist, Jan Carneskog, Ingunn Dybedal, Gunnar Grimfors, Geir E. Tjønnfjord and Mohammad Reza Mirlashari. Their work appears in journals such as Blood, Nutrients and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.